EDIT

Editas Medicine (EDIT)

Editas Medicine Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:EDIT

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/14	19:04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EDIT	Editas Medicine Inc
2024/06/14	16:01	GlobeNewswire Inc.	Editas Medicine Reports New Safety and Efficacy Data from the RUBY Trial of Reni-cel in 18 Patients with Sickle Cell Disease, Presented at the European Hematology Association (EHA) Annual Congress	NASDAQ:EDIT	Editas Medicine Inc
2024/06/14	16:00	GlobeNewswire Inc.	Editas Medicine Announces New Safety and Efficacy Data from the EdiTHAL Trial of Reni-cel in 7 Patients with Transfusion-dependent Beta Thalassemia, Presented at the European Hematology Association (EHA) Annual Congress	NASDAQ:EDIT	Editas Medicine Inc
2024/06/07	05:17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EDIT	Editas Medicine Inc
2024/06/07	05:16	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EDIT	Editas Medicine Inc
2024/06/04	06:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EDIT	Editas Medicine Inc
2024/06/04	06:13	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EDIT	Editas Medicine Inc
2024/06/04	05:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EDIT	Editas Medicine Inc
2024/06/04	05:27	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EDIT	Editas Medicine Inc
2024/06/04	05:25	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EDIT	Editas Medicine Inc
2024/06/01	05:21	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:EDIT	Editas Medicine Inc
2024/06/01	05:20	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:EDIT	Editas Medicine Inc
2024/06/01	05:18	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EDIT	Editas Medicine Inc
2024/05/23	05:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EDIT	Editas Medicine Inc
2024/05/10	19:00	GlobeNewswire Inc.	Editas Medicine Preclinical Data Highlights Advancement of in vivo Gene Editing Medicine Technologies at the American Society of Gene and Cell Therapy Annual Meeting	NASDAQ:EDIT	Editas Medicine Inc
2024/05/09	05:21	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:EDIT	Editas Medicine Inc
2024/05/08	21:29	IH Market News	U.S. Futures Slightly Dip Amid Corporate Earnings and Quiet Economic Calendar, Oil Prices Fall	NASDAQ:EDIT	Editas Medicine Inc
2024/05/08	20:08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EDIT	Editas Medicine Inc
2024/05/08	20:00	GlobeNewswire Inc.	Editas Medicine Announces First Quarter 2024 Results and Business Updates	NASDAQ:EDIT	Editas Medicine Inc
2024/05/02	20:00	GlobeNewswire Inc.	Editas Medicine Announces First Quarter 2024 Results Conference Call and Upcoming Investor Events	NASDAQ:EDIT	Editas Medicine Inc
2024/05/01	21:00	GlobeNewswire Inc.	Editas Medicine and Bristol Myers Squibb Extend Alpha-Beta T Cell Collaboration	NASDAQ:EDIT	Editas Medicine Inc
2024/04/23	05:31	GlobeNewswire Inc.	Editas Medicine to Present Pre-clinical Data Demonstrating Progression of in vivo Medicines Pipeline at the American Society of Gene and Cell Therapy Annual Meeting	NASDAQ:EDIT	Editas Medicine Inc
2024/03/06	10:06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EDIT	Editas Medicine Inc
2024/03/06	10:03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EDIT	Editas Medicine Inc
2024/03/06	10:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EDIT	Editas Medicine Inc
2024/03/06	09:54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EDIT	Editas Medicine Inc
2024/03/05	07:58	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:EDIT	Editas Medicine Inc
2024/02/29	07:13	Edgar (US Regulatory)	Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers	NASDAQ:EDIT	Editas Medicine Inc
2024/02/29	06:39	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:EDIT	Editas Medicine Inc
2024/02/28	21:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EDIT	Editas Medicine Inc